טוען...
Role of Vesicular Monoamine Transporter 2 Inhibitors in Tardive Dyskinesia Management
Tardive dyskinesia (TD) is a distressing and disabling movement disorder that occurs with the use of chronic neuroleptic medications. TD is defined as involuntary athetoid or choreiform movements of head, trunk or limbs. Tongue, lower face, jaw, and extremities are commonly involved but pharyngeal,...
שמור ב:
| הוצא לאור ב: | Cureus |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cureus
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6802812/ https://ncbi.nlm.nih.gov/pubmed/31641566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5471 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|